Showing results (91-100 of 145) with videos related to
Sort By:
Pageof 15
Frontiers in Physiology|July 30, 2019
Metabolic Reprogramming Promotes Myogenesis During AgingRoberta Belli, Agnese Bonato, Luciana De Angelis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancerFederica Di Nicolantonio, Miriam Martini, Francesca Molinari, et al.Italian Journal of Pediatrics|July 14, 2021
The Investigational Clinical Center: a clinical-supportive and patient-centered trial unit model. Ten years of experience through normal and pandemic times of a large pediatric trial center in ItalyGiuseppe Pontrelli, Marco Ciabattini, Franco De Crescenzo, et al.Diagnostics (Basel, Switzerland)|November 27, 2021
Sarcopenia Diagnosis: Reliability of the Ultrasound Assessment of the Tibialis Anterior Muscle as an Alternative Evaluation ToolMassimiliano Leigheb, Alessandro de Sire, Matteo Colangelo, et al.Cancers|December 30, 2025
A Real-World Experience on the Efficacy of First-Line Treatment with Immune-Checkpoint Inhibitors in Non-Small-Cell Lung Cancer Patients with PD-L1 Expression ≥50%: The Role of KRAS MutationsLucia Motta, Samantha Epistolio, Jana Pankovics, et al.Journal of Clinical Medicine|July 29, 2025
Prognostic Impact of KRAS-TP53 Co-Mutations in Patients with Early-Stage Non-Small Cell Lung Cancer: A Single-Center Retrospective StudyLucia Motta, Francesca Molinari, Jana Pankovics, et al.Human Immunology|April 29, 2009
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian populationSilvia Angeletti, Sara Galluzzo, Daniele Santini, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 3, 2021
Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapiesFioravante Capone, Matteo Lucchini, Elisabetta Ferraro, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2012
KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumorsClaudia Miranda, Martina Nucifora, Francesca Molinari, et al.Glycobiology|April 30, 2015
NEU3 activity enhances EGFR activation without affecting EGFR expression and acts on its sialylation levelsAlessandra Mozzi, Matilde Forcella, Alice Riva, et al.Pageof 15